General
Preferred name
ACAMPROSATE
Synonyms
ACAMPROSATE CALCIUM ()
Acamprosatum ()
Calcium N-acetylhomotaurinate ()
N-Acetylhomotaurine Calcium ()
calcium acetylhomotaurinate ()
Campral EC ()
Alcomed ()
Sobriol ()
acarbose ()
Acamprosate (calcium) ()
NSC-759186 ()
SN-102 ()
Campral ()
Acamprosato ()
Acamprosate (calcium salt) ()
Acamprosate-d3 (calcium salt) ()
P&D ID
PD009865
CAS
77337-76-9
56180-94-0
77337-73-6
1225580-94-8
Tags
available
drug
Approved by
FDA
First approval
2004
Drug indication
Alcohol dependence
Drug Status
approved
investigational
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Acamprosate is a NMDA glutamate receptor antagonist and a positive allosteric modulator of GABAA receptors.
Marketed formulations contain acamprosate calcium (PubChem CID 155434). (GtoPdb)
Marketed formulations contain acamprosate calcium (PubChem CID 155434). (GtoPdb)
DESCRIPTION
GluK1 antagonist; inhibits carbonic anhydrase (CA) II and IV; also positive allosteric modulator of GABAA receptors
(Tocris Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
26
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
Guide to Pharmacology
Ki Database
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Other bioactive compounds
Prestwick Chemical Library
ReFrame library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
67
Molecular Weight
181.04
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
4
Ring Count
0
Aromatic Ring Count
0
cLogP
-0.6
TPSA
83.47
Fraction CSP3
0.8
Chiral centers
0.0
Largest ring
0.0
QED
0.45
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
ionotropic glutamate receptor antagonist
Agonist
mgluR)
NMDA Antagonists
Drugs Acting on Glutamate Receptors (Metabotropic
"mgluR)
Drugs Acting on Glutamate Receptors (Metabotropic"
glutamate receptor antagonist
Target
GABA-A receptor
anion channel
Glutamate [NMDA] receptor
GABAR
GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM5
GABA Receptor
Pathway
Membrane Transporter/Ion Channel
Neuronal Signaling
Primary Target
Miscellaneous GABA
Member status
member
Indication
abstinence from alcohol
Therapeutic Class
Alcohol Deterrents
Source data